Full Text View
Tabular View
No Study Results Posted
Related Studies
Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion
This study is currently recruiting participants.
Verified by Deep Breeze, May 2007
First Received: May 14, 2007   No Changes Posted
Sponsored by: Deep Breeze
Information provided by: Deep Breeze
ClinicalTrials.gov Identifier: NCT00473291
  Purpose

The primary purpose of this study is evaluate the VRI device's accuracy in diagnosis of pleural effusion (in comparison to chest x-ray and ultrasonography), and to assess the pleural effusion location and size. The VRI system uses pressure sensors (electronic stethoscopes) to record the energy created by the airflow in the lungs during breathing.


Condition
Pleural Effusion

U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title: Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion

Further study details as provided by Deep Breeze:

Estimated Enrollment: 80
Study Start Date: November 2006
Estimated Study Completion Date: November 2007
Detailed Description:

The accumulation of excess fluid in the pleural cavity of the lungs, known as pleural effusion, is a common clinical condition that may be the result of trauma or disease. Diagnosis and management of pleural effusion can be done by X-Ray or ultrasound; however X-Ray emits radiation, requires a special room and expert personnel, while ultrasound requires a high level of expertise to perform and analyze. The VRI device is non-invasive and radiation free.

The VRI device is a simple method to image the lungs in a regional manner to examine changes that occur during pleural effusion.

Comparison: X-ray and ultrasonography evaluations of pleural effusion, compared to VRI acoustic imaging evaluations.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Able and willing to read, understand, and provide written Informed Consent;
  • Male or Female in the age range of 18-85 years;
  • Subject is suspected to have pleural effusion;
  • Body mass index (BMI) > 21.

Exclusion Criteria:

  • Chest wall deformation;
  • Spine deformation (including severe scoliosis);
  • Hirsutism;
  • Potentially contagious skin lesion on the back;
  • Skin lesion that would interfere with sensor placement;
  • Cardiac pacemaker or implantable defibrillator;
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00473291

Contacts
Contact: Anantham Devanand, M.D. 617-632-8350 danantha@bidmc.harvard.edu
Contact: Kimberly Hall 617-632-8353 KLHALL@bidmc.harvard.edu

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center, Harvard Medical School Recruiting
Boston, Massachusetts, United States, 02215
Principal Investigator: Armin Ernst, M.D.            
Sponsors and Collaborators
Deep Breeze
Investigators
Principal Investigator: Armin Ernst, M.D. Beth Israel Deaconess Medical Center
  More Information

Publications:
Study ID Numbers: DB029
Study First Received: May 14, 2007
Last Updated: May 14, 2007
ClinicalTrials.gov Identifier: NCT00473291     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Deep Breeze:
pleural effusion
lung sounds
acoustic monitoring

Study placed in the following topic categories:
Pleural Effusion
Respiratory Sounds
Respiratory Tract Diseases
Pleural Diseases

Additional relevant MeSH terms:
Pleural Effusion
Respiratory Tract Diseases
Pleural Diseases

ClinicalTrials.gov processed this record on May 06, 2009